Brief: Sensei Biotherapeutics Appoints Patrick Gallagher As Chief Business Officer
01/06/2022 12:41
June 1 (Reuters) - Sensei Biotherapeutics Inc SNSE.O :
* SENSEI BIOTHERAPEUTICS APPOINTS PATRICK GALLAGHER, MBA,
MPH, AS
CHIEF BUSINESS OFFICER
Source text for Eikon: ID:nGNX5Pq9cd
Further company coverage: SNSE.O
Recent news on Faeth Therapeutics,
See all newsBrief: Sensei Biotherapeutics Announces Name Change To Faeth Therapeutics
Brief: Sensei Biotherapeutics Doses First Patient In Phase 1B/2 Trial Of Piktor In Hr+/Her2- Advanced Breast Cancer
Brief: Sensei Biotherapeutics Reports Full Year 2025 Financial Results And Provides Corporate Update
Brief: Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)